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Abstract
Hundreds of genetic association studies on asthma-related phenotypes have been conducted in
different populations. To date, variants in 64 genes have been reported to be associated with
asthma or related traits in at least one study. Of these, 33 associations were replicated in a second
study, 9 associations were not replicated either in a second study or a second sample in the same
study, and 22 associations were reported in just a single published study. These results suggest the
potential for a great amount of heterogeneity underlying asthma. However, many of these studies
are methodologically limited and their interpretation hampered by small sample sizes.
Review
Two general approaches have been widely used to study
the genetics of asthma: genome-wide linkage studies fol-
lowed by positional cloning and candidate gene associa-
tion studies. The results of linkage studies for asthma have
been described in detail elsewhere [1-3]; this review
focuses on the published candidate gene association stud-
ies for asthma.
Candidate gene approach: basic principles and potential 
problems
"Candidate genes" are selected because their biological
function suggests that they could play a role in the patho-
physiology of asthma (such as genes encoding cytokines
and their receptors, chemokines and their receptors, tran-
scription factors, IgE receptor, etc.). Association studies
between variation in these candidate genes and asthma-
related phenotypes are mostly conducted in unrelated
case and unrelated control samples by comparing allele or
genotype frequencies between samples. Association stud-
ies with candidate genes are appealing because they are
hypothesis-driven and can identify genetic variation that
has relatively modest effects on susceptibility [4]. Com-
pared with linkage analysis, case-control studies are much
simpler to perform and less costly because they do not
require the collection of families. However, the interpreta-
tion of association studies is not always straightforward
(for example, see ref. [5]). In particular, there are a large
number of negative association studies with candidate
genes that are never reported. Because the reported p-val-
ues are rarely adjusted for the total number of studies per-
formed (both reported and unreported), the type I error
rate in the reported studies is actually higher than the
nominal level.
A statistically significant association between a variant in
a candidate gene and a disease phenotype can have three
possible explanations. (1) The marker allele truly affects
gene function by altering the amino-acid sequence or by
modifying splicing, transcriptional properties, or mRNA
stability, and thereby directly affects disease risk. (2) The
marker allele is in linkage disequilibrium (LD) with the
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true disease-causing variant. LD, or allelic association, is
the nonrandom association of alleles at linked loci in
populations, and will usually only be detected over small
distances (≤ 60 approximated kb) [6,7], although LD over
longer distances has been observed. Thus, the marker
allele must be located in relatively close proximity to the
disease-causing variant. (3) The association is a false-pos-
itive result (type I error). Using a p-value of 0.05 as the
threshold for significance will result in a 5% type I error
rate. However, in most cases p-values are calculated using
large sample approximations. As a result, the probability
of type I errors for many of these approximations is higher
than the nominal p-value when the sample size is small,
as it is in most published studies. Further, false-positive
results are more likely if multiple comparisons are made,
either with multiple polymorphisms in the same gene,
polymorphisms in multiple genes, or with multiple phe-
notypes. In these cases, the 5% false positive rate expected
when the null hypothesis (of no association) is rejected at
p < 0.05 no longer applies because there is a 5% type I
error rate expected with each independent comparison
(for example, with polymorphisms in different genes). A
common correction for multiple comparisons is to multi-
ply the p-values by the number of comparisons (known as
a Bonferroni correction). Therefore, in a study of 10 vari-
ants, one would need to obtain a p-value of 0.005 to have
the equivalent of a 5% type I error rate. However, the Bon-
ferroni correction can be overly conservative if the multi-
ple tests correspond to correlated variables. For example,
phenotypes are often correlated (e.g., asthma and IgE lev-
els) as are the genotypes of single nucleotide polymor-
phisms (SNPs) that are in LD. Thus, these comparisons do
not represent independent tests and the Bonferroni cor-
rection can be extreme in these circumstances. In fact, the
Bonferonni correction can be conservative even for inde-
pendent tests [8]. Because there is no simple correction for
multiple correlated comparisons, alternative methods to
correct for the error rates are used. Permutation tests are
useful because they preserve the correlation structure of
the data and provide accurate p-values. They can be used
to control the probability of committing any type 1 error
and this can lead to stringent thresholds in studies with a
large number of candidate genes. An alternative approach
is to control the False Discovery Rate (FDR) [9], which is
the proportion of false positives in the set of rejected
hypotheses. FDR is a more liberal rate to control, so it is
more powerful.
Type I errors can also result from genotyping errors, par-
ticularly if there is a systematic error such as overcalling
one genotype over another. This is particularly worrisome
in case-control studies in unrelated individuals because
Mendelian error checks cannot be performed as they can
for family studies. One way to minimize this is to make
sure that the genotypes in the cases and controls are in
Hardy-Weinberg proportions. Systematic errors in geno-
typing will often yield genotype frequencies that are not in
Hardy-Weinberg proportions. In fact, there are a surpris-
ingly large number of published associations that either
did not check for Hardy-Weinberg equilibrium or pre-
sented data that were not in Hardy-Weinberg proportions
[10]. When published association studies of a variety of
diseases were re-examined, 12% of the 133 SNPs reported
were not in Hardy-Weinberg equilibrium in the controls,
suggesting genotyping error. Further, the proportion of
SNPs that deviated from equilibrium was higher among
the SNPs for which a positive association was reported
[10]. Some of these markers were not identified by the
authors as showing deviations from equilibrium. One
explanation for this could be that they used an incorrect
test of significance, which may not be uncommon (e.g.
[11,12]). In particular, for a biallelic marker with three
genotypes (such as for SNPs), the significance testing for
Hardy-Weinberg equilibrium is based on a 1-degree of
freedom test. On the other hand, markers showing depar-
ture from Hardy-Weinberg equilibrium should not be
automatically discarded because deviation from Hardy-
Weinberg equilibrium among cases is expected for vari-
ants close to a susceptibility locus under many genetic
models [13-15]. Nevertheless, markers that show devia-
tions from expectations should be closely scrutinized and
retyped to ensure that they are genotyped correctly. Lastly,
type I errors can result from population substructure, or
sampling cases and controls that differ with respect to eth-
nic background. Because allele frequencies vary among
ethnic groups, great care must be taken to assure that case
and control subjects have similar ethnic compositions. If
they differ, an allele may be significantly more frequent in
the cases compared with controls due to differences in
ethnicity, but this may be misinterpreted as an association
with the disease. Methods are now available to directly
test for stratification and to correct for any imbalances
[16,17], but these require genotyping the case and control
samples for 30 or more informative loci (i.e., loci that dis-
criminate between pairs of racial or ethnic groups [17]).
Another approach to address the problem of population
admixture is to conduct family-based association studies
with analytical methods that are robust to population
admixture, such as the transmission disequilibrium test
(TDT) [18]. These methods have become increasingly
popular in genetic studies of complex disorders, although
they are uniformly less powerful than studying an equiva-
lent number of unrelated cases and controls.
Not all associations that are not replicated are false posi-
tive results. An association may not be replicated because
of different patterns of LD in different populations. Differ-
ences in LD patterns can be caused by differences in allele
frequencies and/or the presence of more than one causal
variant. Although there are no examples of this, it remainsRespiratory Research 2003, 4 http://respiratory-research.com/content/4/1/14
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a theoretical possibility. This can be addressed by examin-
ing haplotypes instead of single SNPs. Many studies have
now shown that examining multiple SNPs as haplotypes
is often preferable to single SNP analysis [19,20]. A haplo-
type is composed of alleles at different loci that are inher-
ited together on the same chromosome. Thus, even if the
disease-causing variant itself is not identified, a shared
haplotype that contains the disease variant will be more
common in cases than in controls. This could in addition
help to identify the true susceptibility variant. On the
other hand, an association may not be replicated because
the phenotype is defined differently between studies. For
example, the phenotype "atopy" has been defined as a
positive skin prick test [SPT], a positive RAST test, high
total serum IgE, or a combination of these tests. Although
these phenotypes are clearly related, it is likely that some
genes that influence total IgE levels do not influence spe-
cific IgE response to allergens, and vice versa.
Lastly, positive associations may not be replicated because
the true model of genetic susceptibility for diseases such
as asthma and atopy is complex. It is most likely that any
particular susceptibility variant has a relatively minor
effect on the phenotype and that the magnitude of its
effect will be influenced by genes at other loci (gene-gene
interactions) [21,22] and by the environmental factors
(gene-environment interactions) [23-25]. In fact, some
variants may only confer susceptibility in combination
with other genes (epistasis) or in certain environments.
Because background genes and environmental factors dif-
fer between populations it would not be surprising if asso-
ciations with single SNPs or haplotypes differed between
populations.
Review of the association study literature
We searched the public databases for published candidate
gene association studies of asthma and related pheno-
types, using keywords "association" or "case-control"
together with each of the following: "asthma", "bronchial
hyperresponsiveness", "BHR", "atopy", "SPT", "atopic
dermatitis", "IgE", and "drug response". We identified
199 studies with at least one significant association
reported. These studies identified 64 genes as potential
susceptibility loci. We then searched for all other associa-
tion studies with variants in these 64 genes (Table 1 [see
Additional file 1]). For this analysis, we considered an ini-
tial association replicated if at least one other study found
an association with variation in the same gene, but not
necessarily with the same variant. Using these criteria, 33
gene associations were replicated and 9 associations were
not replicated either in a second study or in a second sam-
ple in the same study. Additionally, 22 genetic associa-
tions were only reported in a single study, i.e. replication
studies have not been published, even though it is likely
that at least some have been performed. In this regard, the
establishment of a database of non-significant candidate
gene studies would helpful for prioritizing genes for
genetic studies and would therefore benefit the asthma
genetics community overall. Nonetheless, the results of
this survey underline the potential for a great amount of
heterogeneity underlying asthma. However, many of
these studies have been conducted in small samples
(<100 cases and controls), few correct for multiple testing,
and in many cases, replication studies were performed in
different ethnic groups than those studied in the original
report. Lastly, in only 34.8 % of studies, all markers were
reported to be in Hardy-Weinberg equilibrium, while in
2.2 % of studies at least one marker was reported to devi-
ate from equilibrium, and in the majority of studies (63
%) testing for Hardy-Weinberg proportions was not men-
tioned at all.
Regardless of these caveats, some genes stand out because
they were associated with asthma-phenotypes rather con-
sistently across studies and populations. In particular, var-
iation in eight genes have been associated with asthma-
phenotypes in five or more studies: interleukin-4 (IL4),
interleukin-13 (IL13), β2 adrenergic receptor (ADRB2),
human leukocyte antigen DRB1 (HLA-DRB1), tumor
necrosis factor (TNF), lymphotoxin-alpha (LTA), high-
affinity IgE receptor (FCER1B) and IL-4 receptor (IL4RA).
These loci likely represent true asthma or atopy suscepti-
bility loci or genes important for disease modification. An
example of the latter is the ADRB2 gene, which has been
more consistently associated with asthma severity than
with asthma or atopy per se.
Conclusions
Variants in 64 genes have been associated with asthma or
atopy phenotypes in at least one study, although many of
these studies are methodologically limited and need rep-
lication. In the future, association studies incorporating
gene-gene and gene-environment interactions may help
to disentangle some of the complexities of these diseases
and explain some of the discrepant results. Lastly, the
development of guidelines for establishing appropriate
thresholds for significance in association studies would
impose more rigorous standards on candidate gene stud-
ies, similar to what is now standard for linkage studies
[26], and the creation of a database for unpublished asso-
ciation studies would be helpful for evaluating the overall
evidence for association of asthma or atopy candidate
genes.
List of abbreviations
AD atopic dermatitis
Alt a Alternaria alternata
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Bet v Betula verucosa (birch pollen)
BHR bronchial hyperresponsiveness
Can f Canis familiaris (dog allergen)
Der p Dermatophagoides pteronyssinus (house dust mite
allergen)
FDR false discovery rate
Fel d Felis domesticus (cat allergen)
FEV1 forced exspiratory volume in the first second
FVC forced vital capacity
HDM house dust mite
IgE immunoglobulin E
LD linkage disequilibrium
Lol p Lolium perenne (rye grass pollen)
Ole e Olea Europaea (olive pollen)
Par o Parietaria officinalis
Phl p Phleum pratense (Timothy grass pollen)
SNP single nucleotide polymorphism
SPT skin prick test
RAST radio allergo sorbent test
TDT transmission disequilibrium test
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